{"id":"https://openalex.org/W2040907355","doi":"https://doi.org/10.1021/jm800981y","title":"The Design, Synthesis, and Antiviral Activity of 4\u2032-Azidocytidine Analogues against Hepatitis C Virus Replication: The Discovery of 4\u2032-Azidoarabinocytidine","display_name":"The Design, Synthesis, and Antiviral Activity of 4\u2032-Azidocytidine Analogues against Hepatitis C Virus Replication: The Discovery of 4\u2032-Azidoarabinocytidine","publication_year":2008,"publication_date":"2008-12-05","ids":{"openalex":"https://openalex.org/W2040907355","doi":"https://doi.org/10.1021/jm800981y","mag":"2040907355","pmid":"https://pubmed.ncbi.nlm.nih.gov/19055482"},"language":"en","primary_location":{"id":"doi:10.1021/jm800981y","doi":"https://doi.org/10.1021/jm800981y","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm800981y","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"David B. Smith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David B. Smith","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056893882","display_name":"Genadiy Kalayanov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Genadiy Kalayanov","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078187729","display_name":"Christian J. Sund","orcid":"https://orcid.org/0000-0002-9226-0007","observed_orcids":["https://orcid.org/0000-0002-9226-0007"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christian Sund","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030303667","display_name":"Anna Winqvist","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Winqvist","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056475233","display_name":"Pedro Guilherme Lacerda Ferreira Pinho","orcid":"https://orcid.org/0000-0001-5588-7794","observed_orcids":["https://orcid.org/0000-0001-5588-7794"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pedro Pinho","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107891699","display_name":"Tatiana V. Maltseva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tatiana Maltseva","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059807734","display_name":"V\u00e9ronique Morisson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Veronique Morisson","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028994393","display_name":"Vincent L\u00e9v\u00eaque","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vincent Leveque","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084489776","display_name":"Sonal Rajyaguru","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sonal Rajyaguru","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063577342","display_name":"Sophie Le Pogam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sophie Le Pogam","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065719560","display_name":"Isabel N\u00e1jera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isabel Najera","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019489345","display_name":"Kurt Benkestock","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kurt Benkestock","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103184210","display_name":"Xiaoxiong Zhou","orcid":"https://orcid.org/0000-0001-9088-3553","observed_orcids":["https://orcid.org/0000-0001-9088-3553"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiao-Xiong Zhou","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087446722","display_name":"Hans Maag","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans Maag","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112178377","display_name":"Nick Cammack","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nick Cammack","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107640198","display_name":"Joseph A. Martin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph A. Martin","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031250605","display_name":"Steven Swallow","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Swallow","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113715532","display_name":"Nils Gunnar Johansson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nils Gunnar Johansson","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076998022","display_name":"Klaus Klumpp","orcid":"https://orcid.org/0000-0002-4829-3127","observed_orcids":["https://orcid.org/0000-0002-4829-3127"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Klaus Klumpp","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061004952","display_name":"Mark A. Smith","orcid":"https://orcid.org/0000-0001-8939-4269","observed_orcids":["https://orcid.org/0000-0001-8939-4269"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mark Smith","raw_affiliation_strings":["Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, California 94304, Medivir AB, Department of Medicinal Chemistry, Lunastigen 7, SE-141 44 Huddinge, Sweden","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5061004952"],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":3.9094,"has_fulltext":false,"cited_by_count":46,"citation_normalized_percentile":{"value":0.9317123,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"52","issue":"1","first_page":"219","last_page":"223"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.8980000019073486},{"id":"https://openalex.org/keywords/ns5b-rna-dependent-rna-polymerase","display_name":"NS5B RNA-dependent RNA polymerase","score":0.8999999761581421},{"id":"https://openalex.org/keywords/antiviral-nucleoside-analogues","display_name":"antiviral nucleosides","score":0.9039999842643738},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8999999761581421},{"id":"https://openalex.org/keywords/subgenomic-replicon","display_name":"subgenomic replicon","score":0.7509999871253967},{"id":"https://openalex.org/keywords/hcv-genotype-1b","display_name":"HCV genotype 1b","score":0.7429999709129333},{"id":"https://openalex.org/keywords/antiviral-drug-design","display_name":"antiviral drug design","score":0.6859999895095825}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8971575498580933},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6184366345405579},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.6158157587051392},{"id":"https://openalex.org/C12590798","wikidata":"https://www.wikidata.org/wiki/Q3933199","display_name":"Replication (statistics)","level":2,"score":0.6152673363685608},{"id":"https://openalex.org/C140704245","wikidata":"https://www.wikidata.org/wiki/Q3933202","display_name":"Viral replication","level":3,"score":0.5343794822692871},{"id":"https://openalex.org/C2781463415","wikidata":"https://www.wikidata.org/wiki/Q2082778","display_name":"Hepacivirus","level":4,"score":0.5296858549118042},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5244819521903992},{"id":"https://openalex.org/C2777510210","wikidata":"https://www.wikidata.org/wiki/Q1331256","display_name":"Flaviviridae","level":4,"score":0.4670281410217285},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.4570198059082031},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2351631224155426},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20133554935455322},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm800981y","doi":"https://doi.org/10.1021/jm800981y","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm800981y","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:19055482","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19055482","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W1997448570","https://openalex.org/W2012474791","https://openalex.org/W2026122224","https://openalex.org/W2027545702","https://openalex.org/W2037686553","https://openalex.org/W2046953953","https://openalex.org/W2062395204","https://openalex.org/W2072291558","https://openalex.org/W2075410973","https://openalex.org/W2091179185","https://openalex.org/W2105769862","https://openalex.org/W2106196384","https://openalex.org/W2119713419"],"related_works":["https://openalex.org/W2036535362","https://openalex.org/W1997448570","https://openalex.org/W2095558996","https://openalex.org/W2106196384","https://openalex.org/W2072291558","https://openalex.org/W1965852252","https://openalex.org/W2118376130","https://openalex.org/W2324915322","https://openalex.org/W2012474791","https://openalex.org/W2046912297"],"abstract_inverted_index":{"4'-Azidocytidine":[0],"3":[1],"(R1479)":[2],"has":[3],"been":[4],"previously":[5],"discovered":[6],"as":[7],"a":[8],"potent":[9,51],"and":[10,31,47],"selective":[11],"inhibitor":[12],"of":[13,21,34,37,61,77],"HCV":[14],"replication":[15],"targeting":[16],"the":[17,29,41,44,65],"RNA-dependent":[18],"RNA":[19],"polymerase":[20],"hepatitis":[22],"C":[23],"virus,":[24],"NS5B.":[25],"Here":[26],"we":[27],"describe":[28],"synthesis":[30],"biological":[32],"evaluation":[33],"several":[35],"derivatives":[36],"4'-azidocytidine":[38],"by":[39],"varying":[40],"substituents":[42],"at":[43],"ribose":[45],"2'":[46],"3'-positions.":[48],"The":[49,71],"most":[50],"compound":[52],"in":[53,64],"this":[54,75],"series":[55,76],"is":[56],"4'-azidoarabinocytidine":[57],"with":[58],"an":[59],"IC(50)":[60],"0.17":[62],"microM":[63],"genotype":[66],"1b":[67],"subgenomic":[68],"replicon":[69],"system.":[70],"structure-activity":[72],"relationships":[73],"within":[74],"nucleoside":[78],"analogues":[79],"are":[80],"discussed.":[81]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}